GE HealthCare Technologies Inc. (GEHC)

Market Cap	32.87B
Revenue (ttm)	19.97B
Net Income (ttm)	2.24B
Shares Out	456.56M
EPS (ttm)	4.88
PE Ratio	14.75
Forward PE	15.50
Dividend	$0.14 (0.19%)
Ex-Dividend Date	Jul 25, 2025

Volume	2,714,935
Open	71.20
Previous Close	71.10
Day's Range	71.01 - 72.09
52-Week Range	57.65 - 94.80
Beta	1.28
Analysts	Strong Buy
Price Target	89.10 (+23.75%)
Earnings Date	Jul 30, 2025

About ACCD

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided ther...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1892
• Employees: 53,000
• Stock Exchange: NASDAQ
• Ticker Symbol: GEHC
• Website: https://www.gehealthcare.com

Financial Performance

In 2024, GEHC's revenue was $19.67 billion, an increase of 0.61% compared to the previous year's $19.55 billion. Earnings were $1.99 billion, an increase of 43.90%.

Analyst Summary

According to 10 analysts, the average rating for GEHC stock is "Strong Buy." The 12-month stock price target is $89.1, which is an increase of 23.75% from the latest price.

Price Target

$89.1

(23.75% upside)

Analyst Consensus: Strong Buy